Zobrazeno 1 - 10
of 35
pro vyhledávání: '"C. J. M. Van Noesel"'
Autor:
W. S. M. E. Theelen, O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. van Noesel, D. S. Peeper, M. M. van den Heuvel, K. Schulze
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis allows us to perform comprehensive immunoprofiling and may assist in dissecting the different components of the immune infiltrate. As gene expre
Externí odkaz:
https://doaj.org/article/debbea0e0b5047e685a2c5ef50af7bd0
Autor:
Jeroen E. J. Guikema, Koen Wagner, M. J. Kwakkenbos, Aldo Jongejan, C. J. M. Van Noesel, Richard J. Bende, Thera A. M. Wormhoudt, A. C. M. van Kampen, Linda M. Slot, Aranka V Ballering
Publikováno v:
Leukemia, 33(5), 1219-1230. Nature Publishing Group
In the past years, the genomes of thousands of tumors have been elucidated. To date however, our knowledge on somatic gene alterations in normal cells is very limited. In this study, we demonstrate that tetanus-specific human memory B lymphocytes car
Autor:
Thomas Kuilman, Oscar Krijgsman, Daniel S. Peeper, M. van den Heuvel, Dennis Peters, Katja Schulze, Maarten A. Ligtenberg, Sten Cornelissen, Kim Monkhorst, Willemijn S. M. E. Theelen, Stefan M. Willems, J. L. G. Blaauwgeers, C. J. M. van Noesel
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, 18, 1
Journal of Translational Medicine, 18
Journal of translational medicine, 18(1):271. BioMed Central Ltd.
Journal of translational medicine, 18(1):271. BioMed Central
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Journal of Translational Medicine, 18, 1
Journal of Translational Medicine, 18
Journal of translational medicine, 18(1):271. BioMed Central Ltd.
Journal of translational medicine, 18(1):271. BioMed Central
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Background The tumor immune microenvironment is a heterogeneous entity. Gene expression analysis allows us to perform comprehensive immunoprofiling and may assist in dissecting the different components of the immune infiltrate. As gene expression ana
Autor:
Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
Additional file 2: Figure S1. A) Flowchart of samples for NanoString analysis. B) QC data NanoString: positive/negative controls and keratin expression. C) The 34-gene signature does not work on TCGA RNA-seq data: unmeasurable or low expression of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29fc61c83c177e00f4611c106b59819b
Autor:
Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
Additional file 3. Patients’ and tumor characteristics of the non-small cell lung cancer cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f29fe0c4eb9b40da70eb51077b50e1b
Autor:
Theelen, W. S. M. E., O. Krijgsman, K. Monkhorst, T. Kuilman, D. D. G. C. Peters, S. Cornelissen, M. A. Ligtenberg, S. M. Willems, J. L. G. Blaauwgeers, C. J. M. Van Noesel, D. S. Peeper, M. M. Van Den Heuvel, K. Schulze
Additional file 4: Figure S2. Boxplots of the associations between the immune response genes and the 34-gene signature with PD-L1 expression on tumor cells (TC) and immune cells (IC) and CD8 infiltration in the tumor margin and in the tumor center.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b7c367c3dff752fc8da8a852cae6a3
Autor:
Timon A. Bloedjes, E. E. Eldering, Marcel Spaargaren, G. de Wilde, Jeroen E. J. Guikema, C. J. M. Van Noesel, Chiel Maas, Richard J. Bende, S. T. Pals
The phosphatidylinositide-3 kinases (PI3K) and the downstream mediator AKT drive survival and proliferation of multiple myeloma (MM) cells and several AKT inhibitors are currently being tested in clinical trials for MM patients. AKT inhibition has pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76d8f9f4e66d8a4d0de1e116d0122f7
https://doi.org/10.1101/816694
https://doi.org/10.1101/816694
Autor:
Jeroen E. J. Guikema, Aldo Jongejan, Thera A. M. Wormhoudt, M. J. Kwakkenbos, Linda M. Slot, A. H. C. van Kampen, Richard J. Bende, C. J. M. Van Noesel
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Sjogren’s syndrome (SS) is the autoimmune disease with the highest risk of lymphoma development. SS patients develop most frequently MALT lymphoma and to a lesser extent diffuse large B-cell lymphoma (DLBCL). Previously, we have shown th
Autor:
H.E. Teulings, Gabrielle Krebbers, L. Nieuweboer-Krobotova, J.P.W. van der Veen, Rosalie M. Luiten, Karin J. Willemsen, Esther P. M. Tjin, C. J. M. Van Noesel, E.H. Kemp
Publikováno v:
British Journal of Dermatology. 168:733-738
Summary Background Melanoma is an immunogenic tumour. The development of skin depigmentation or melanoma-associated leucoderma (MAL) has been associated with favourable clinical outcome in patients with metastatic melanoma, especially after immunothe
Autor:
Jan Paul Medema, Louis Vermeulen, Evelyn Fessler, S C Oppeneer, C. J. M. Van Noesel, Marnix Jansen, Evelien Dekker, Hans M. Rodermond, Raju Kandimalla, F De Sousa E Melo, Pramudita R. Prasetyanti, Giorgio Stassi, Xin Wang, J H de Jong, Janneke F. Linnekamp, S R van Hooff, Lan Zhao, Marek Franitza
Publikováno v:
Oncogene
Europe PubMed Central
Oncogene, 35(46), 6026-6037. Nature Publishing Group
Europe PubMed Central
Oncogene, 35(46), 6026-6037. Nature Publishing Group
Colorectal cancer (CRC) is a heterogeneous disease posing a challenge for accurate classification and treatment of this malignancy. There is no common genetic molecular feature that would allow for the identification of patients at risk for developin